MS: Immunology Flashcards

1
Q

List the types and locations of key cells in MS lesions

A

CD4+/CD8+: perivascular cuffs and intra-parenchyma

B-cells: (aggregated or as ectopic lymphoid follicles) perivascular and meningeal

Macrophages: (laden w/ myelin) in + around lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Main cells implicated in MS pathology?

A
  • Th1
  • Th17
  • Anti-inflam CD4+ helper cells (Th2 and T-Reg)
  • Cytotoxic CD8+ cells
  • M1/M2 microglia
  • (and macrophages)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the cell pathology in the early stages of MS

A

MAJORITY of INFLAMMATORY CELLS: monocytes + macrophages

T-lymphocytes infiltration in early stages (only a few in parenchyma during active demyelination)

B-lymphocytes in small numbers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mechanisms through which autoimmunity is prevented (regulatory)?

A

NORMALLY:

  • NK T-cell upregulation -> kills less tolerant T-cells

[infection] -> DCs present interact w/ T-cells -> regulatory cytokines (IL-10 + TGF-b) -> tolerance to self

Th1 -> can also maintain tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mechanisms for induction of autoimmunity (pro-inflammatory)?

A

[in response to virus/bacteria] -> DCs activate and prime lymphocytes -> already-autoreactive T-cells OR induce autoreactive T-cells

Bystander activation: T-cell receptor independent immune cell activation (no DCs making contact)]- cytokines induce autoreactive T-cells

Cross-reactivity w/ self peptides in susceptible T-cells (response to self by accident since they look similar)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the bystander effect?

A

T-cell receptor independent immune cell activation (no DCs making contact)

Cytokines -> T-cell activation -> response against self

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

EBV histochemistry w/ MS

A

Immunohistochemistry shows detection of B-cells infected w/ EBV in post mortem MS brain tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

EBV and MS epidemiological studies

A

~100% seropositivity for EBV in MS compared to 90% in healthy
AND
much higher MS risk w/ higher anti-EBNA IgG titres than lower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Role of EBV in MS?

A

Infects B-cells (persistent latent infection)

NB: events leading to immune activation in MS are unclear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

1/4:

Describe the cellular events events in early MS (up to and including T-cell activation)

A

APC (DC) presents autoreactive antigen on CD4 T-cell -> CD4 differentiates

  • > proinflammatory: CD4 Th1 and CD4 Th17
  • > anti-inflammatory: CD4 Th2 and CD4 Treg

Response is amplified by CD8 cells (cytotoxic and MAIT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

2/4:

Describe cellular events after T-cell activation

A

Activated T-cells extravasate into blood parenchyma

[DCs further activate pro-inflam T-cells -> increased damage]

Entry into CNS via BBB or blood-CSF barrier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

3/4:

Cellular events of MS after T-cells in brain

A

B-cells migrate into parenchyma and differentiate into plasma cell -> Ig production -> inflammation

[IgG oligoclonal bands]

Macrophages produce reactive-oxygen-species (ROS) -> axonal damage

Microglia primed to M1 (pro-infl) or M2 (anti-infl)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

4/4:

Cellular events of MS in neurons

A

Neuronal death -> neurodegradation

Inflammation -> immune cell infiltration -> inflamm + cyotoxic damage -> axonal/neuronal damage

other mechanisms: loss of synapses, Wallerian degeneration (retrograde + anterograde)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Proinflammatory effects in early MS?

A

Extravasation of autoreactive cells -> induces M1 microglia -> neurotoxic mediators -> neuronal death -> protein debris -> DC capture antigens and go to lymph nodes -> vicious cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

TH1:

What t.factor induces it’s Dx?
What does it produce?
What are its homing receptors?

A
  • Requires IL-12 for - differentiation from naive T
  • Produces IFN-gamma
  • CCR5 and CXCR3

[MS activity correlates w/ IFN-g]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

TH17:

What t.factor induces it’s Dx?
What does it produce?
What are its homing receptors?

A

Requires IL-23
Produces IL-17
CCR6 and CCR4

[increased IL-17 producing cells in MS lesions] and [IL-23 deficient mice are resistant to EAE]

17
Q

Anti-inflammatory effects in early MS

A

Induction of M2 microglia -> maintain tolerance in CNS

18
Q

Relevance of Th2 in MS?

A

Produce anti-inflammatory cytokines (IL-4, IL-5, IL-13)

19
Q

What does Th2 and T-Reg produce?

A

Th2 Produce: IL-4, IL-5, IL-13 (all anti-inflammatory)

T-Reg produces: TGF-b and IL-10

[NB: CD25 component of IL-2 receptor has been identified- essential for T-reg development]

20
Q

Location of CD8 cytotoxic T-cells and mucosal-associated invariant (MAIT) T-cells in MS

A

CD8 Cytotoxic: found at the edge of lesions and in perivascular areas

MAIT: gut lymphocyte found in post mortem MS brain tissue]- can infiltrate CNS in MS

22
Q

NK cells:

What do they produce?
What is their receptor?

A

Produce IFN-gamma

Express CD56 receptor

23
Q

Desrcibe M1 microglia features (and how it’s triggered)

A

Injured neurons release pro-inflam mediators -> M1

M1 -> phagocytosis + cytokine release -> neuronal death (MS lesion

24
Q

Regulatory CD8+ T-cell examples?

A
  • CD57+

- CD103+

25
Q

Genetic susceptibility to MS?

A

GWAS shows relationship w/ MS and HLA class II immune genes: IL-7R, IL-24-alpha. CD58

  • Gut microbiome influences autoimmunity
  • Dietary fatty acids influence GI T-cell differentiation: long chain FA -> Th1/Th17; short chain FA -> Treg
26
Q

CSF in MS

A
  • oligoclonal bands (>90% of MS cases)
  • increased leukocytes
  • increased protein in CSF
27
Q

Mechanisms for MS treatment

A

Immune-modulatory

no regenerative/neuroprotective therapies

28
Q

MS treatment and indications?

A
  • immunomodulatory (1st line): injectables (IFN-b, GA); orals (dimeth fumarate, teriflunomide)
  • acute relapse: high-dose corticosteroids
  • block immune cell entry: to CNS- Natalizumab, in periph- Gylenia
  • Modulate/neutralise immune cells- Daclizumab
  • Immunosuppress/depleting- Alemtuzumab
  • RRMS: autologous haematopoetic stem cell transplant (AHSCT)
29
Q

Comorbidities for MS?

A

MS associated w/ increased incidence of other AI conditions (esp thyroiditis) and asymp. auto-Ab